Answered step by step
Verified Expert Solution
Question
1 Approved Answer
Long-term debt Notes payable, 11% 8% convertible bonds payable 11% bonds payable Total long-term debt Shareholders' equity Preferred stock, 6% cumulative, $50 par value,
Long-term debt Notes payable, 11% 8% convertible bonds payable 11% bonds payable Total long-term debt Shareholders' equity Preferred stock, 6% cumulative, $50 par value, 108,000 shares authorized, 27,000 shares issued and outstanding Common stock, $1 par, 10,200,000 shares authorized, 1,020,000 shares issued and outstanding Additional paid-in capital Retained earnings Total shareholders' equity The following transactions have also occurred at Novak. $980,000 4,910,000 5,910,000 $11,800,000 $1,350,000 1,020,000 3,970,000 6,050,000 $12,390,000 1. Options were granted on July 1, 2024, to purchase 180,000 shares at $15 per share. Although no options were exercised during fiscal year 2025, the average price per common share during fiscal year 2025 was $20 per share. 2. Each bond was issued at face value. The 8% convertible bonds will convert into common stock at 50 shares per $1,000 bond. The bonds are exercisable after 5 years and were issued in fiscal year 2024. 3. The preferred stock was issued in 2024. 4. There are no preferred dividends in arrears; however, preferred dividends were not declared in fiscal year 2025. 5. The 1,020,000 shares of common stock were outstanding for the entire 2025 fiscal year. 6. Net income for fiscal year 2025 was $1,480,000, and the average income tax rate is 20%. For the fiscal year ended June 30, 2025, calculate the following for Novak Pharmaceutical Industries. (Round answers to 2 decimal places, e.g. 2.45.) a. Basic earnings per share. Basic earnings per share b. Diluted earnings per share. Diluted earnings per share
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started